ResearcherSheng Jing HospitalNo recent work listed
Zhen Liu
Matched on ORCID iD 0000-0002-1436-1574; OpenAlex author ID A5100632352. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper
Papers 4
- Retraction Note: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine. Co-author DOI 10.1038/s41598-023-48298-9↗
- Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling pathway. Last author DOI 10.1007/s13105-020-00734-4↗
- The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine. Co-author DOI 10.1038/s41598-018-26496-0↗
- Expression of stromal cell-derived factor 1 and CXCR7 ligand receptor system in pancreatic adenocarcinoma. Co-author DOI 10.1186/1477-7819-12-348↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiansheng Lin · 2 shared papers, 2018–2023 · strength 0.28
- Paper Retraction Note: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances t… DOI 10.1038/s41598-023-48298-9↗
- Paper The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic ef… DOI 10.1038/s41598-018-26496-0↗
- Qiang Huang · 2 shared papers, 2018–2023 · strength 0.28
- Paper Retraction Note: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances t… DOI 10.1038/s41598-023-48298-9↗
- Paper The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic ef… DOI 10.1038/s41598-018-26496-0↗
- Fang Xie · 2 shared papers, 2018–2023 · strength 0.28
- Paper Retraction Note: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances t… DOI 10.1038/s41598-023-48298-9↗
- Paper The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic ef… DOI 10.1038/s41598-018-26496-0↗
- Baosheng Wang · 2 shared papers, 2014–2020 · strength 0.21
- Paper Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling p… DOI 10.1007/s13105-020-00734-4↗
- Paper Expression of stromal cell-derived factor 1 and CXCR7 ligand receptor system in pancreatic adenocarcinoma. DOI 10.1186/1477-7819-12-348↗
- Xiangpeng Meng · 2 shared papers, 2014–2020 · strength 0.21
- Paper Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling p… DOI 10.1007/s13105-020-00734-4↗
- Paper Expression of stromal cell-derived factor 1 and CXCR7 ligand receptor system in pancreatic adenocarcinoma. DOI 10.1186/1477-7819-12-348↗
- Xin Wu · 1 shared paper, 2020 · strength 0.15
- Jia Ma · 1 shared paper, 2020 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.